Skip to main content

Advertisement

SpringerLink
Log in

Epidemiology and prevention of cutaneous melanoma

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Melanoma incidence has continued to increase in all white populations, and mortality from melanoma remains high in older men worldwide. In Australia, Europe, and the United States, a substantial number of thick melanomas in older men are of the nodular subtype, a subtype lacking asymmetry or color change. Educating the public and pro-fessionals about the significance of evolving pigmented lesions as emphasized in the revised ABCDE of pigmented lesions is relevant. Targeting screening efforts toward older men will be necessary to decrease worldwide melanoma mortality. Among preven-tion strategies, emphasizing multiple methods of sun protection in early childhood, adolescence, and adulthood is needed to decrease sunburn rates. Chemoprevention research in melanoma should become a research priority to complement ongoing prevention strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lens MB, Dawes M: Global perspectives of contemporary epidemiological trends of cutaneous malignant mela-noma. Br J Dermatol 2004, 150:179–185.

    Article  PubMed  CAS  Google Scholar 

  2. Jhappan C, Noonan FP, Merlino G: Ultraviolet radia-tion and cutaneous malignant melanoma. Oncogene 2003, 22:3099–3112.

    Article  PubMed  CAS  Google Scholar 

  3. Nelemans PJ, Groenendal H, Kiemeney LA: Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 1993, 101: 252.

    Article  PubMed  CAS  Google Scholar 

  4. Elwood JM, Gallagher RP, Hill GB, Pearson JC: Cutaneous melanoma in relation to intermittent and constant sun exposure--The Western Canada Melanoma Study. Int J Cancer 1985, 35:427.

    Article  PubMed  CAS  Google Scholar 

  5. Armstrong BK, Kricker A: How much melanoma is caused by sun exposure. Melanoma Res 1993, 3:395–401.

    Article  PubMed  CAS  Google Scholar 

  6. Tucker MA, Goldstein AM: Melanoma etiology: where are we. Oncogene 2003, 22:3042–3052.

    Article  PubMed  CAS  Google Scholar 

  7. van der Velden PA, Sandkuijl LA, Bergman W, et al.: Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001, 69:774–779.

    Article  PubMed  Google Scholar 

  8. Whiteman DC, Watt P, Purdie DM, et al.: Melanocytic nevi, solar keratoses, and divergent pathways to cuta-neous melanoma. J Natl Cancer Inst 2003, 95:806–812. This study provides support for divergent pathways to cutaneous melanoma.

    Article  PubMed  Google Scholar 

  9. Curtin JA, Fridlyand J, Kageshita T, et al.: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353:2135–2147. This is the first detailed report highlighting genetic diversity in cutaneous melanoma.

    Article  PubMed  CAS  Google Scholar 

  10. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10–30.

    Article  PubMed  Google Scholar 

  11. Geller AC, Miller DR, Annas GD, et al.: Melanoma inci-dence and mortality among US whites, 1969-1999. JAMA 2002, 288:1719–1720.

    Article  PubMed  Google Scholar 

  12. Jemal A, Devesa SS, Hartge P, Tucker MA: Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001, 93:678–683.

    Article  PubMed  CAS  Google Scholar 

  13. Demierre MF, Chung C, Miller DR, Geller AC: Early detection of thick melanomas in the US? “Beware≓ of the nodular subtype. Arch Dermatol 2005, 141:745–750.

    Article  PubMed  Google Scholar 

  14. Chamberlain AJ, Fritschi L, Giles GG, et al.: Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002, 138:609–614.

    Article  PubMed  Google Scholar 

  15. Bergenmar M, Ringborg U, Mansson Brahme E, Brandberg Y: Nodular histogenetic type--the most significant factor for thick melanoma: implications for prevention. Melanoma Res 1998, 8:403–411.

    Article  PubMed  CAS  Google Scholar 

  16. Crocetti E, Carli P: Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol 2003, 13:72–75.

    PubMed  Google Scholar 

  17. Swetter SM, Boldrick JC, Jung SY, et al.: Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005, 125:685–691.

    Article  PubMed  CAS  Google Scholar 

  18. MacKie R: Melanoma incidence in the west of Scotland over 25 years. Proceedings of the 6th World Congress on Melanoma. Vancouver, Canada, September 6–10 2005.

  19. de Vries E, Bray FI, Coebergh JW, Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003, 107: 119–126.

    Article  PubMed  CAS  Google Scholar 

  20. de Vries E, Schouten LJ, Visser O, et al.: Rising trends in the incidence of and mortality from cutaneous mela-noma in the Netherlands: a Northwest to Southeast gradient. Eur J Cancer 2003, 39:1439–1446.

    Article  PubMed  Google Scholar 

  21. Edwards BK, Brown ML, Wingo PA, et al.: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treat-ment. J Natl Cancer Inst 2005, 97:1407–1427.

    Article  PubMed  Google Scholar 

  22. deVries E, Bray FI, Coebeergh JWW, Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mor-tality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003, 107: 119–126.

    Article  PubMed  CAS  Google Scholar 

  23. Bosetti C, La Vecchia C, Naldi L, et al.: Mortality from cutaneous malignant melanoma in Europe. Has the epidemic leveled off? Melanoma Res 2004, 14:301–309.

    Article  PubMed  Google Scholar 

  24. Cayuela A, Rodriguez-Dominguez S, Lapetra-Peralta J, Conejo-Mir JS: Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001. Br J Dermatol 2005, 152:997–1000.

    Article  PubMed  CAS  Google Scholar 

  25. Geller AC, Sober AJ, Zhang Z, et al.: Strategies for improving melanoma education and screening for men age > or = 50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer 2002, 95:1554–1561.

    Article  PubMed  Google Scholar 

  26. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356 patients following organ trans-plantation. Br J Dermatol 2000, 143:513–519.

    PubMed  CAS  Google Scholar 

  27. Hollenbeak CS, Todd MM, Billingsley EM, et al.: Increased incidence of melanoma in renal transplantation recipi-ents. Cancer 2005, 104: 1962–1967.

    Article  PubMed  Google Scholar 

  28. Strouse JJ, Fears TR, Tucker MA, Wayne AS: Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005, 23:4735–4741.

    Article  PubMed  Google Scholar 

  29. Hu S, Ma F, Collado-Mesa F, Kirsner RS: UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 2004, 140:819–824.

    Article  PubMed  Google Scholar 

  30. Eide MJ, Weinstock MA: Association of UV index, lati-tude, and melanoma incidence in nonwhite popula-tions—US Surveillance, Epidemiology, and End Results (SEER) Program, 1992-2001. Arch Dermatol 2005, 141:477–481.

    Article  PubMed  Google Scholar 

  31. Berwick M, Armstrong BK, Ben-Porat L, et al.: Sun expo-sure and mortality from melanoma. J Natl Cancer Inst 2005, 97:195–199. A study eliciting novel hypotheses in regard to chronic sun exposure and melanoma.

    Article  PubMed  Google Scholar 

  32. Webb AR, DeCosta BR, Holick MF: Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 1989, 68:882–887.

    Article  PubMed  CAS  Google Scholar 

  33. Egan KM, Sosman JA, Blot WJ: Sunlight and reduced risk of cancer: is the real story vitamin D. J Natl Cancer Inst 2005, 97:161–163.

    Article  PubMed  CAS  Google Scholar 

  34. Lim HW, Gilchrest BA, Cooper KD, et al.: Sunlight, tan-ning booths, and vitamin D. J Am Acad Dermatol 2005, 52:868–876.

    Article  PubMed  Google Scholar 

  35. Rhodes AR: Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer. Cancer 1995, 75:613.

    Article  PubMed  CAS  Google Scholar 

  36. Godar DE, Urback F, Gasparro FP, van der Leun JC: UV doses of young adults. Photochem Photobiol 2003, 77:453–457. A relevant update on actual amount of UV exposure received by each age group.

    Article  PubMed  CAS  Google Scholar 

  37. Robinson JK, Rigel DS, Amonette RA: Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol 1997, 37:179–186.

    Article  PubMed  CAS  Google Scholar 

  38. Benjes LS, Brooks DR, Zhang Z, et al.: Changing patterns of sun protection between the first and second sum-mers for very young children. Arch Dermatol 2004, 140:925–930.

    Article  PubMed  Google Scholar 

  39. McGuire-Eisen M, Rothman K, Demierre MF: The ABCs of sun protection for children. Dermatol Nurs 2006, In press.

  40. Gallagher RP, Rivers JK, Lee TK, et al.: Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA 2000, 283:2955–2960.

    Article  PubMed  CAS  Google Scholar 

  41. Diffey BL: Sunscreens and melanoma: the future looks bright. Br J Dermatol 2005, 153:378–381.

    Article  PubMed  CAS  Google Scholar 

  42. Mahler HI, Kulik JA, Harrell J, et al.: Effects of UV photo-graphs, photoaging information, and use of sunless tan-ning lotion on sun protection behaviors. Arch Dermatol 2005, 141:373–380.

    Article  PubMed  Google Scholar 

  43. Lindholm C, Andersson R, Dufmats M, et al.: Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004, 101: 2067–2078.

    Article  PubMed  Google Scholar 

  44. Institute of Medicine: Extending Medicare Coverage for Prevention and Other Services. Washington DC: National Academy Press; 2000.

    Google Scholar 

  45. Abbasi NR, Shaw HM, Rigel DS, et al.: Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004, 292:2771–2776.

    Article  PubMed  CAS  Google Scholar 

  46. Demierre MF, Nathanson L: Chemoprevention of mela-noma: an unexplored strategy. J Clin Oncol 2003, 21: 158–165.

    Article  PubMed  Google Scholar 

  47. Edwards BK, Howe HL, Ries LA, et al.: Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002, 94:2766–2792.

    Article  PubMed  Google Scholar 

  48. Lippman SM, Hong WK: Cancer prevention science and practice. Cancer Res 2002, 62:5119–5125.

    PubMed  CAS  Google Scholar 

  49. Demierre MF, Sondak VK: Cutaneous melanoma: patho-genesis and rationale for chemoprevention. Crit Rev Oncol Hematol 2005, 53:225–239. An important review on the rationale for chemoprevention in melanoma.

    Article  PubMed  Google Scholar 

  50. Demierre MF, Lippman SM, Higgins P, Gruber S: Statins and cancer prevention. Nat Rev Cancer 2005, 5:930–942.

    Article  PubMed  CAS  Google Scholar 

  51. Demierre MF, Sondak VK: Chemoprevention of mela-noma: theoretical and practical considerations. Cancer Control J 2005, 12:219–222.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Skin Oncology Program, Boston Medical Center, 720 Harrison Avenue-DOB 801A, 02118, Boston, MA, USA

    Marie-France Demierre MD, FRCPC

Authors
  1. Marie-France Demierre MD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demierre, MF. Epidemiology and prevention of cutaneous melanoma. Curr. Treat. Options in Oncol. 7, 181–186 (2006). https://doi.org/10.1007/s11864-006-0011-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-006-0011-z

Keywords

Search

Navigation